NO794047L - Fremgangsmaate ved fremstilling av terapeutisk virksomme imidazolinderivater. - Google Patents
Fremgangsmaate ved fremstilling av terapeutisk virksomme imidazolinderivater.Info
- Publication number
- NO794047L NO794047L NO794047A NO794047A NO794047L NO 794047 L NO794047 L NO 794047L NO 794047 A NO794047 A NO 794047A NO 794047 A NO794047 A NO 794047A NO 794047 L NO794047 L NO 794047L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- therapeutically effective
- imidazoline derivatives
- imidazoline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/22—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT30738/78A IT1101727B (it) | 1978-12-12 | 1978-12-12 | Nuove 2-fenilammino-imidazoline-(2) sostituite, dotate di particolari proprieta' terapeutiche, loro processo di sintesi e composizioni farmaceutiche |
| IT27202/79A IT1127215B (it) | 1979-11-12 | 1979-11-12 | Nuove 2-fenilammino-imidazoline-(2)sostitutite,dotate di particolari proprieta' terapeutiche,loro processo di sintesi e composizioni farmaceutiche |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO794047L true NO794047L (no) | 1980-06-13 |
| NO152171B NO152171B (no) | 1985-05-06 |
| NO152171C NO152171C (no) | 1985-08-14 |
Family
ID=26328719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO794047A NO152171C (no) | 1978-12-12 | 1979-12-11 | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme imidazolinderivater |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4262006A (no) |
| CA (1) | CA1137090A (no) |
| CH (1) | CH645358A5 (no) |
| DE (1) | DE2949971C2 (no) |
| DK (1) | DK159317C (no) |
| ES (1) | ES8102565A1 (no) |
| FI (1) | FI65428C (no) |
| FR (1) | FR2444036A1 (no) |
| GB (1) | GB2041355B (no) |
| NL (1) | NL183139C (no) |
| NO (1) | NO152171C (no) |
| PT (1) | PT70584A (no) |
| SE (1) | SE430503B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4398028A (en) * | 1977-01-14 | 1983-08-09 | Sandoz Ltd. | Bicyclic heterocyclic amino derivatives |
| KR101881115B1 (ko) * | 2015-06-25 | 2018-08-20 | 가천대학교 산학협력단 | 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD95843A5 (no) * | 1971-01-21 | 1973-02-20 | ||
| US3850926A (en) * | 1971-01-21 | 1974-11-26 | Boehringer Sohn Ingelheim | 2-(n-substituted-phenylamino)-imidazolines-(2) |
-
1979
- 1979-11-28 FI FI793727A patent/FI65428C/fi not_active IP Right Cessation
- 1979-11-29 CH CH1061279A patent/CH645358A5/it not_active IP Right Cessation
- 1979-11-29 CA CA000340891A patent/CA1137090A/en not_active Expired
- 1979-12-03 DK DK512479A patent/DK159317C/da not_active IP Right Cessation
- 1979-12-04 GB GB7941802A patent/GB2041355B/en not_active Expired
- 1979-12-06 US US06/100,833 patent/US4262006A/en not_active Expired - Lifetime
- 1979-12-07 NL NLAANVRAGE7908853,A patent/NL183139C/xx not_active IP Right Cessation
- 1979-12-10 SE SE7910157A patent/SE430503B/sv not_active IP Right Cessation
- 1979-12-11 FR FR7930361A patent/FR2444036A1/fr active Granted
- 1979-12-11 NO NO794047A patent/NO152171C/no unknown
- 1979-12-11 ES ES487167A patent/ES8102565A1/es not_active Expired
- 1979-12-12 DE DE2949971A patent/DE2949971C2/de not_active Expired
- 1979-12-12 PT PT70584A patent/PT70584A/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES487167A0 (es) | 1980-12-16 |
| GB2041355B (en) | 1983-02-16 |
| DK159317C (da) | 1991-02-25 |
| SE7910157L (sv) | 1980-06-13 |
| NL7908853A (nl) | 1980-06-16 |
| NL183139B (nl) | 1988-03-01 |
| DE2949971A1 (de) | 1980-07-03 |
| SE430503B (sv) | 1983-11-21 |
| DE2949971C2 (de) | 1983-11-24 |
| FR2444036A1 (fr) | 1980-07-11 |
| FI65428C (fi) | 1984-05-10 |
| ES8102565A1 (es) | 1980-12-16 |
| CA1137090A (en) | 1982-12-07 |
| FI793727A (fi) | 1980-06-13 |
| US4262006A (en) | 1981-04-14 |
| CH645358A5 (it) | 1984-09-28 |
| FI65428B (fi) | 1984-01-31 |
| PT70584A (en) | 1980-01-01 |
| DK512479A (da) | 1980-06-13 |
| NO152171B (no) | 1985-05-06 |
| DK159317B (da) | 1990-10-01 |
| NO152171C (no) | 1985-08-14 |
| FR2444036B1 (no) | 1985-03-15 |
| NL183139C (nl) | 1988-08-01 |
| GB2041355A (en) | 1980-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO794069L (no) | Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater. | |
| NO151588C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater | |
| NO790358L (no) | Fremgangsmaate for fremstilling av alkylendiaminderivater | |
| NO790257L (no) | Fremgangsmaate ved fremstilling av 9-desoksy-9a-metylen-isostere av pgi2 | |
| NO792787L (no) | Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler | |
| NO801155L (no) | Fremgangsmaate ved fremstilling av acyl-carnitinamider | |
| NO152935C (no) | Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater. | |
| NO802913L (no) | Fremgangsmaate ved fremstilling av cephalosporinforbindelse | |
| ES494635A0 (es) | Procedimiento de preparacion de derivados de tiadiazol | |
| NO791831L (no) | Fremgangsmaate for fremstilling av aminotiazoler | |
| NO154522C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. | |
| NO792404L (no) | Fremgangsmaate for fremstilling av imidazolderivater | |
| NO147560C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater | |
| NO151201C (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater | |
| NO152255C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere | |
| NO150966C (no) | Fremgangsmaate for fremstilling av kationiske stivelsespastaer | |
| NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
| NO791139L (no) | Fremgangsmaate for fremstilling av lysergolderivater | |
| NO152787C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner. | |
| NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
| NO155539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater. | |
| NO147310C (no) | Fremgangsmaate for fremstilling av substituerte antitumorantracykliner | |
| NO791220L (no) | Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner | |
| NO790328L (no) | Fremgangsmaate ved fremstilling av derivater av nafthyl-1-eddiksyre. | |
| NO153730C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 10-brom-e-homo-eburnan. |